Idaho’s Epidiolex Expanded Access Program hit a new double-digit milestone recently. 15 children are now enrolled and taking part in the program, and another 7 are scheduled for screenings.

A little history…

The governor’s office authorized the establishment of an FDA-approved Epidiolex Expanded Access program for children with treatment-resistant epilepsy in April 2015 and directed the Department of Health and Welfare to oversee it. So we’ve been working with a doctor, the drug company, FDA and the Drug Enforcement Agency to create the program and get it up and running. Dr. Robert Wechsler, who is running the program, began screening and enrolling children in December.  Continue reading “Idaho’s Epidiolex Expanded Access Program has now enrolled 15 children” →